Trial intelligence / Profile preview

Anti-IL-6 antibody in the psoriasis transplant model

NL-OMON34138Active, not recruiting

Sponsor
argenx
Start
Sep 2010
Countries
1
01

Overview

Open-label trial in psoriasis and plaque psoriasis (2 arms), sponsored by argenx. Primary endpoint: Development of psoriatic changes in the transplant model. Started Sep 2010; status: active, not recruiting.

02

Conditions

psoriasisplaque psoriasis

Beyond the preview

Go deeper on NL-OMON34138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call